Lisa A Ridnour, William F Heinz, Robert Ys Cheng, Adelaide L Wink, Noemi Kedei, Milind Pore, Fatima Imtiaz, Elise L Femino, Ana L Gonzalez, Leandro Coutinho, Donna Butcher, Elijah F Edmondson, M Cristina Rangel, Robert J Kinders, Stanley Lipkowitz, Stephen Tc Wong, Stephen K Anderson, Danial W McVicar, Xiaoxian Li, Sharon A Glynn, Timothy R Billiar, Jenny C Chang, Stephen M Hewitt, Stefan Ambs, Stephen J Lockett, David A Wink
Estrogen receptor-negative (ER-) breast cancer is an aggressive breast cancer subtype with limited therapeutic options. Upregulated expression of both inducible nitric oxide synthase (NOS2) and cyclo-oxygenase (COX2) in breast tumors predicts poor clinical outcomes. Signaling molecules released by these enzymes activate oncogenic pathways, driving cancer stemness, metastasis, and immune suppression. The influence of tumor NOS2/COX2 expression on the landscape of immune markers using multiplex fluorescence imaging of 21 ER-breast tumors were stratified for survival...
December 23, 2023: bioRxiv